Study Finds Intermittent Fasting May Alleviate Chronic Pain and Cognitive Issues
A study conducted by researchers at the First Affiliated Hospital of Zhengzhou University in China has revealed that intermittent fasting may have beneficial effects on chronic pain and its associated cognitive issues. This research builds on existing knowledge regarding the neurological connections between the brain and the digestive system, particularly the importance of gut bacteria in maintaining cognitive health. Chronic pain affects millions of individuals worldwide and often leads to mental health challenges, including anxiety and depression. Current treatment approaches typically address these conditions separately, focusing on either pain relief or mental health support.
The relationship between chronic pain and cognitive function is believed to be closely linked to the brain-gut axis. Factors such as nerve function breakdown, hormonal imbalances, and changes in gut microbiota may contribute to this connection. While previous studies have suggested that intermittent fasting could provide analgesic effects through hormone signaling, neural repair, and reduced brain inflammation, there has been limited research on its impact on the mental health aspects of chronic pain.
To investigate this further, the researchers utilized mice engineered to experience various forms of long-term discomfort, including pain from constrictive injuries and inflammation. Over a period of 38 days, these mice alternated between feeding days and fasting days, while a control group had continuous access to food. The animals underwent a series of tests to evaluate pain sensitivity, anxiety-like behaviors, gut microbiota composition, metabolites, and neuroinflammation.
The findings indicated that the mice subjected to intermittent fasting exhibited reduced pain responses and cognitive deficits compared to the control group. Notably, fasting mice with constrictive injury-related pain showed a significant decrease in anxiety-like behaviors. Additionally, these fasting mice demonstrated improvements in gut barrier function and a reduction in nervous system inflammation. The composition of their gut microbiota also changed, with an increase in the bacteria species Alistipes finegoldii.
To further explore these results, the researchers introduced Alistipes finegoldii into the gut of non-fasting mice, which replicated many of the analgesic and cognitive benefits observed in the fasting group. They also identified hippuric acid, a compound produced by gut bacteria during the breakdown of specific nutrients, as a potential key player in this therapeutic pathway. Hippuric acid was found to activate a neuroimmune pathway known as the Stimulator of Interferon Genes (STING).
While these findings provide a promising connection between intermittent fasting, gut microbiota, and neuroinflammation, it is essential to note that intermittent fasting is not a definitive cure for chronic pain or anxiety. Further research is necessary to fully understand the Alistipes finegoldii–hippuric acid–STING neuroimmune axis and its implications for treatment. However, the study suggests that incorporating intermittent fasting into a medically supervised diet may offer additional benefits for managing chronic pain and its cognitive impacts.




